By Dennis Thompson HealthDay ReporterTHURSDAY, March 12, 2026 (HealthDay News) — People frequently switch between different weight-loss drugs, swapping Ozempic for Zepbound and vice versa within the ...

Even if you’re logging strong miles, age-related muscle loss can creep in. The fix is surprisingly straightforward.

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists like Ozempic®, Wegovy®, Mounjaro®, and Zepbound®. While Ozempic can be great ...

Loss of muscle mass, also called muscle wasting or atrophy, can happen gradually as part of getting older or more suddenly due to underlying medical conditions. Other factors can contribute, like ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

Modern weight loss treatments have transformed how we approach obesity management, but they come with concerning side effects. The growing use of glucagon-like peptide-1 medications has highlighted an ...

Revolutionizing Medical Weight Loss with GLP-1 Therapy Bellingham, United States - February 25, 2026 / Mt. Baker ...

A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this ...

A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1 receptor agonist drugs produce broadly consistent weight-loss results across age, race, ethnicity, and ...

A new study shows that popular weight‑loss drugs may help the heart after a person has a heart attack. These drugs are already used to help people lose weight or treat diabetes. Now researchers think ...